All Categories
Tirzepatide

Tirzepatide

Home >  Modality  >  Proteins  >  GLP-1  >  Tirzepatide

Modality

Tirzepatide

Description of Tirzepatide

Tirzepatide is a dual receptor agonist targeting glucagon-like peptide-1 (GLP-1) receptor and insulinotropic polypeptide (GIP) receptor. Tirzepatide, developed by Lilly, is a chemically synthetic first-in-class peptide therapeutics for patients with type 2 diabetes, obesity, or overweight. It is licensed under the trade names Mounjaro and Zepbound.

Structural formula of tirzepatide

 

Yaohai Bio-Pharma offers tirzepatide as an active pharmaceutical ingredient (API)

API, active substance

Application

Tirzepatide, GIP/GLP dual agonist

Tirzepatide API for injection formulation

 

Get a Free Quote

Get in touch